Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and pharmacokinetics of antipsychotics in children with autism
NL-OMON47545Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of risperidone, pipamperone and aripiprazole in Autism Spectrum Disorder (ASD) (3 cohorts), sponsored by Erasmus MC. Primary endpoints: Pharmacokinetic model and Weight change. Started Aug 2016; status: active, not recruiting.
02
Drugs
risperidonepipamperonearipiprazole
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NL-OMON47545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47545.